Table 3. Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve acute and recently HIV-1 infected MSM volunteers from Coastal Kenya, 2005–2017 (N = 97).

Volunteer	Risk group	Age at EDI	Year of EDI	HIV-1 subtype	PI mutations	NRTI mutations	NNRTIs mutations
0014	MSME	26.4	2006	A1	none	D67N	none
0059	MSMW	25.3	2009	A1	none	none	K101E
0078	MSMW	27.1	2010	A1	none	none	K103N
0087	MSMW	26.7	2010	A1	none	none	K103N
0098	MSMW	27.2	2011	A1	none	M184V	Y181C
2239	MSMW	28.7	2014	A1	none	none	K103N
2402	MSMW	24.5	2013	A1	none	none	K103N
2437	MSME	22.6	2014	A1	none	none	K103N

Abbreviations: EDI (estimated date of infection), MSME (men who have sex with men, exclusively), MSMW (men who have sex with men, and women), PI (Protease inhibitors), NRTI (Nucleoside Reverse Transcriptase Inhibitors), NNRTI (Non-Nucleoside Reverse Transcriptase Inhibitors).